Main page content

Displaying results 31 - 40 of 77
Publication ID: SMA13-4755PARTNERKIT
Published:

Provides parents of children ages 9 to 15 with the tools and information they need to start talking with their children early about the dangers of alcohol. Includes a suite of materials that helps reinforce the underage drinking prevention campaign's messages.

Publication ID: SMA16-BARO-2015
Published:

This report presents national data about the prevalence of behavioral health conditions. This data includes the rate of serious mental illness, suicidal thoughts, substance use, and underage drinking. The report also highlights the percentages of those who seek treatment for these conditions. Access state barometer reports.

Publication ID: SMA15-4910KOR
Published:

This Korean-language brochure gives patients information on buprenorphine and medication-assisted treatment for opioid use disorder. It describes addiction and withdrawal, how buprenorphine works, its proper use, its side effects, and how it fits with counseling in the recovery process.

Publication ID: SMA15-4154
Published:

This guide contains patient materials for an intensive outpatient treatment course for stimulant misuse. It provides handouts to use in individual and conjoint sessions, and sessions on early recovery skills and relapse prevention.

Publication ID: SMA15-4907
Published:

This manual provides guidance on the use of medication-assisted treatment for alcohol use misuse. It summarizes approved medications, screening and assessment, treatment planning, and patient monitoring.

Publication ID: SMA15-4907POCKETGUID
Published:

This pocket guide is designed as a quick reference for information about medication-assisted treatment for alcohol use disorder. It offers a checklist for prescribing medications to patients and provides a list of approved medications for treatment.

Publication ID: SMA15-4442
Published:

This brochure informs patients about buprenorphine and medication-assisted treatment for opioid use disorder. It describes addiction and withdrawal, how buprenorphine works, its proper use, its side effects, and how it fits with counseling in the recovery process.

Publication ID: SMA15-4895EQ
Published:

This report provides a snapshot of key aspects of behavioral health, serious mental illness, suicidal thoughts, and mental illness, substance use disorders, or both. The information is based on selected determinants of health, including race and ethnicity, income level, geography, and health insurance status.

Publication ID: SMA15-4895
Published:

This report presents national data about the prevalence of behavioral health conditions. This data includes the rate of serious mental illness, suicidal thoughts, substance use, and underage drinking. The report also highlights the percentages of those who seek treatment for these conditions. Access state barometer reports.

Publication ID: SMA14-4892R
Published:

This guide explains how to use extended-release injectable naltrexone as part of medication-assisted treatment (MAT) for opioid use disorder. It covers assessing patients, initiating MAT, monitoring progress, and deciding when to end treatment.

Displaying 31 - 40 out of 77